Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Current Trends in Antibody Drug Conjugates

Dimiter Dimitrov's Biography



Dimiter Dimitrov, Head/Senior Investigator

Dr. Dimitrov graduated and completed his PhD at the University of Sofia, Sofia, Bulgaria, in 1976. Thereafter he worked in the Bulgarian Academy of Sciences where he defended his ScD in 1985 and was Professor of Biophysics until he joined the National Cancer Institute (NCI) of the National Institutes of Health (NIH), USA, in 1990. He was tenured as Senior Investigator in 1993 and appointed at the Senior Biomedical Research Service in 2008. His research group includes molecular biologists who are experts in display/screening/libraries methodologies, antibody engineering, and protein biochemistry, structural biologist and computational scientist. His major long-term goal is the development of clinically useful therapeutics and vaccines based on human monoclonal antibodies including engineered antibody domains. He has authored and coauthored more than 300 articles cited more than 10,000 times, and is inventor or coinventor of more than 50 inventions, patent applications or patents. See also his web site http://ccr.cancer.gov/staff/staff.asp?profileid=5749

Dimiter Dimitrov Image